Genetic advancement in the detection of Systemic Lupus Erythematosus (SLE)

Q3 Biochemistry, Genetics and Molecular Biology Journal of Cellular Biotechnology Pub Date : 2023-11-17 DOI:10.3233/jcb-230121
Akshat Pratap Singh, Mohammad Kamran Shaikh, Anjali Borker, Gulshan R Bandre
{"title":"Genetic advancement in the detection of Systemic Lupus Erythematosus (SLE)","authors":"Akshat Pratap Singh, Mohammad Kamran Shaikh, Anjali Borker, Gulshan R Bandre","doi":"10.3233/jcb-230121","DOIUrl":null,"url":null,"abstract":"The disease lupus, also known as systemic lupus erythematosus (SLE), is an autoimmune condition, chronic in nature, that can affect any organ in the body. The immune system of the body becomes hyperactive in lupus, attacking normal tissues and organs such as the skin, skeletal, renal, brain, heart, lungs, and blood. Normally, the immunologic response protects the body against outside susceptibilities. Periods of illness, known as flares, and times of wellness, known as remissions, are characteristics of lupus. Lupus is challenging to diagnose since its symptoms are vastly adherent and often mistaken for those of other illnesses. The presence of complexities in this illness cannot be proven with a single laboratory test. Lupus has no recognised cause or treatment as of yet. However, research is going on to achieve improved health outcomes, and early identification and treatment are essential. Lupus has no recognised cause or treatment as of yet. Early detection and treatment, which can typically reduce a disease’s severity and course, are essential to enhancing health outcomes. NSAIDs, antimalarials, and steroids (including cortisone and others) are widely used to treat lupus. Patients with lupus may also receive cytotoxic chemotherapy comparable to chemotherapy used to treat cancer. Patients with lupus may also receive cytotoxic chemotherapy comparable to chemotherapy used to treat cancer. This well-known and respected resource has a new edition that blends basic and clinical science to present a translational medicine concept. A helpful resource for professionals in the diagnosis and treatment of Systemic Lupus Erythematous patients, SLE serves as a reference for hospital libraries and as a tool for measuring clinical activity for drug development and fundamental research. Beautifully depicted and in full colour throughout Basic science part has been enhanced to let readers concentrate on the most recent molecular medicine techniques and how they affect the expression and treatment of diseases.","PeriodicalId":15286,"journal":{"name":"Journal of Cellular Biotechnology","volume":"111 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cellular Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/jcb-230121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

The disease lupus, also known as systemic lupus erythematosus (SLE), is an autoimmune condition, chronic in nature, that can affect any organ in the body. The immune system of the body becomes hyperactive in lupus, attacking normal tissues and organs such as the skin, skeletal, renal, brain, heart, lungs, and blood. Normally, the immunologic response protects the body against outside susceptibilities. Periods of illness, known as flares, and times of wellness, known as remissions, are characteristics of lupus. Lupus is challenging to diagnose since its symptoms are vastly adherent and often mistaken for those of other illnesses. The presence of complexities in this illness cannot be proven with a single laboratory test. Lupus has no recognised cause or treatment as of yet. However, research is going on to achieve improved health outcomes, and early identification and treatment are essential. Lupus has no recognised cause or treatment as of yet. Early detection and treatment, which can typically reduce a disease’s severity and course, are essential to enhancing health outcomes. NSAIDs, antimalarials, and steroids (including cortisone and others) are widely used to treat lupus. Patients with lupus may also receive cytotoxic chemotherapy comparable to chemotherapy used to treat cancer. Patients with lupus may also receive cytotoxic chemotherapy comparable to chemotherapy used to treat cancer. This well-known and respected resource has a new edition that blends basic and clinical science to present a translational medicine concept. A helpful resource for professionals in the diagnosis and treatment of Systemic Lupus Erythematous patients, SLE serves as a reference for hospital libraries and as a tool for measuring clinical activity for drug development and fundamental research. Beautifully depicted and in full colour throughout Basic science part has been enhanced to let readers concentrate on the most recent molecular medicine techniques and how they affect the expression and treatment of diseases.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
检测系统性红斑狼疮的基因进步
红斑狼疮又称系统性红斑狼疮(SLE),是一种自身免疫性疾病,属于慢性病,可影响身体的任何器官。狼疮患者体内的免疫系统变得异常活跃,攻击正常的组织和器官,如皮肤、骨骼、肾脏、大脑、心脏、肺部和血液。正常情况下,免疫反应会保护人体免受外界易感因素的侵袭。红斑狼疮的特征是患病期(称为发作期)和康复期(称为缓解期)。红斑狼疮的症状多种多样,常常被误认为是其他疾病的症状,因此诊断难度很大。这种疾病的复杂性无法通过单一的实验室检测来证明。红斑狼疮至今没有公认的病因或治疗方法。不过,目前正在开展研究,以改善健康状况,早期识别和治疗至关重要。红斑狼疮目前还没有公认的病因或治疗方法。早期发现和治疗通常可以减轻疾病的严重程度,缩短病程,这对提高健康水平至关重要。非甾体抗炎药、抗疟药和类固醇(包括可的松等)被广泛用于治疗狼疮。狼疮患者也可以接受与治疗癌症的化疗类似的细胞毒性化疗。狼疮患者也可能接受与治疗癌症的化疗类似的细胞毒性化疗。这本广为人知、备受推崇的资料集在新版中融合了基础和临床科学,提出了转化医学的概念。系统性红斑狼疮》是诊断和治疗系统性红斑狼疮患者的专业人士的有用资源,既可作为医院图书馆的参考资料,也可作为衡量药物开发和基础研究临床活动的工具。全书图文并茂,全彩印刷 基础科学部分的内容得到了加强,使读者能够集中了解最新的分子医学技术,以及这些技术如何影响疾病的表达和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Cellular Biotechnology
Journal of Cellular Biotechnology Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
0.70
自引率
0.00%
发文量
13
期刊最新文献
Some questions about a new study of coefficient microcirculation in example in patients with limb-threatening ischemia and intermittent claudication Functional regulation of hydroxyproline, ascorbic acid and lipid peroxidation during GABA chitosan nanoparticles mediated liver regeneration Periodontal medicine: The bidirectional relationship between osteoporosis and periodontal health In-vitro studies of relative intracellular alterations caused by three variants of Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) Spirulina platensis: A comprehensive review of its nutritional value, antioxidant activity and functional food potential
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1